Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biogen Idec
(NQ:
BIIB
)
141.35
-1.02 (-0.72%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,154,179
Open
141.84
Bid (Size)
141.50 (3)
Ask (Size)
144.75 (1)
Prev. Close
142.37
Today's Range
140.75 - 143.69
52wk Range
139.71 - 244.95
Shares Outstanding
144,000,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok
January 31, 2025
Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on TikTok.
Via
Benzinga
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
January 31, 2025
From
Biogen Inc.
Via
GlobeNewswire
Performance
YTD
-5.77%
-5.77%
1 Month
-5.02%
-5.02%
3 Month
-17.83%
-17.83%
6 Month
-29.69%
-29.69%
1 Year
-41.34%
-41.34%
More News
Read More
Breaking Down Biogen: 18 Analysts Share Their Views
January 28, 2025
Via
Benzinga
Biogen Rises On FDA Nod for Alzheimer's Drug Dosing Regimen, But Sage Deal Fallout Irks Retail
January 27, 2025
Via
Stocktwits
Exposures
Product Safety
Peering Into Biogen's Recent Short Interest
January 09, 2025
Via
Benzinga
17 Analysts Assess Biogen: What You Need To Know
January 02, 2025
Via
Benzinga
10 Worst Performing Large-Caps Last 12 Months
January 27, 2025
Via
Talk Markets
Topics
Stocks / Equities
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
January 26, 2025
From
Biogen Inc.
Via
GlobeNewswire
FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA
January 23, 2025
From
Biogen Inc.
Via
GlobeNewswire
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
January 17, 2025
Via
Benzinga
Topics
Government
Exposures
Political
10 Health Care Stocks With Whale Alerts In Today's Session
January 14, 2025
Via
Benzinga
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
January 14, 2025
Via
Benzinga
Exposures
Product Safety
FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
January 13, 2025
From
Biogen Inc.
Via
GlobeNewswire
Sage Therapeutics Stock Eyes Best Day In 5 Years On Biogen’s Unsolicited Bid: Retail Piles In
January 13, 2025
Via
Stocktwits
Exposures
Product Safety
Biogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analysts
January 13, 2025
Via
Benzinga
Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
January 13, 2025
Via
Benzinga
Exposures
Fossil Fuels
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
January 13, 2025
Via
Benzinga
Why Is Depression-Focused Sage Therapeutics Stock Surging Higher On Monday?
January 13, 2025
Via
Benzinga
Enduring Truths for Investors Both New and Seasoned
January 11, 2025
Via
The Motley Fool
Grid Expansion; Beaten Blues
January 08, 2025
Via
Talk Markets
Topics
Stocks / Equities
Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
January 07, 2025
Via
Benzinga
Denali Therapeutics Ratchets Up Losses On Misstep In ALS Treatment. Why The Game Isn't Over Yet.
January 07, 2025
Via
Investor's Business Daily
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
January 04, 2025
Via
The Motley Fool
Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic
January 03, 2025
Via
Benzinga
10 Worst Performing Large-Caps Last 12 Months
December 26, 2024
Via
Talk Markets
Topics
Stocks / Equities
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.